• OPEN AN ACCOUNT
Indian Indices
Sensex
81,666.46 943.52
( 1.17%)
Global Indices
Nasdaq
48,928.31 -164.26
(-0.33%)
Dow Jones
6,963.16 -26.85
(-0.38%)
Hang Seng
52,813.31 -509.54
(-0.96%)
Nikkei 225
10,322.91 99.37
(0.97%)
Forex
USD-INR
91.66 -0.27
(-0.29%)
EUR-INR
108.61 -1.36
(-1.24%)
GBP-INR
125.41 -1.53
(-1.21%)
JPY-INR
0.59 -0.01
(-1.35%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
205.5515954
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
38.19
754.18
EPS(TTM)
Face Value()
Div & Yield %
16.76
10
0.23
 

Artificial Electronics Intelligent Material hits the roof after multi-fold Q2 profit surge
Nov 07,2025
The standalone net sales soared 813% YoY and 389.63% QoQ to Rs 33.05 crore in Q2 FY26. Net profit surged 4,543% YoY to Rs 9.75 crore, as against Rs 0.21 crore in the same period last year. Sequentially, PAT was up nearly 15 times from Rs 0.61 crore in Q1 FY26. Profit before tax (PBT) jumped 4,372% YoY and 1373.86% QoQ to Rs 12.97 crore in Q2 FY26.

Total expenditure rose 512% YoY and 223.21% QoQ to Rs 20.33 crore during the quarter.

Tax expenses stood at Rs 3.22 crore in Q2 FY26 as against Rs 0.08 crore in Q2 FY25 and Rs 0.11 crore in Q1 FY26. Depreciation remained nominal at Rs 0.03 crore, indicating asset-light operations.

Artificial Electronics Intelligent Material is engaged in the business of developing & providing software consultancy services.